Researchers explain how lymphoma cells metastasise to the brain
Chronic inflammatory processes in ageing brains lead to lymphoma cells that have entered the brain tissue being retained.
List view / Grid view
Chronic inflammatory processes in ageing brains lead to lymphoma cells that have entered the brain tissue being retained.
An experiment with mice has successively blocked the immune system's T cells from killing transplanted cells.
There is an increasing need to expand the variety and complexity of cell-based assays for biologic research and drug discovery.
A ground-breaking nervous system discovery could be significant for the treatment of different neurological diseases.
Using both computational models and stem cell-based experiments, researchers have identified a gene regulator of schizophrenia.
This In-Depth Focus features articles highlighting the importance of effective data management strategies as well as the recent trends in upstream bioprocessing.
This issue includes an investigation into utilising recombinant antibodies for research, a highlight on protein design using computational methods and an examination of the advances in genomic medicine. Also in the issue are articles on next generation sequencing and upstream bioprocessing.
A potential target for ALS has been revealed by a study which found the Fos-B gene encouraged axonal branching.
Scientists combine organ-on-a-chip and stem-cell technologies to make a powerful tool for diabetes research.
Dr Shona Lang investigates the advantages and disadvantages of using organoids within R&D, highlighting the most important questions to ask before using these models.
It has been discovered that Id4 controls whether stem cells enter cell division and may be relevant for treating neurodegenerative disease.
Combining organoid and organ-on-a-chip technologies, researchers have created a model which will allow them to study eye diseases and treatments for the retina.
A new drug target for treating glioblastoma has been identified from a cellular pathway found to contribute to the spread of glioma stem cells.
A new study has shown that mutations in mitochondrial DNA induced by cell reprogramming may trigger an immune response.
Researchers may have fundamentally altered the way scientists study brain diseases with new CRISPR technology.